Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & Validation of Imaging Modality Performance Across the NAFLD Spectrum in a Prospectively Recruited Cohort

NCT05479721 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT05479721
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05479721 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & Validation of Imaging Modality Performance Across the NAFLD Spectrum in a Prospectively Recruited Cohort
Lead sponsor
University of Oxford
Phase
Observational
Overall status
Active, not recruiting
Start date
September 4, 2019
Completion date
October 31, 2025
Enrollment
450 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

fibrosis, liver, nafld, nash, nash - nonalcoholic steatohepatitis, steatosis of liver